ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 180 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,798 | +12.7% | 40,447 | +16.2% | 0.00% | – |
| Q2 2023 | $128,457 | +5.8% | 34,813 | -5.1% | 0.00% | – |
| Q1 2023 | $121,366 | -12.6% | 36,667 | +2.1% | 0.00% | – |
| Q4 2022 | $138,880 | +59.6% | 35,926 | 0.0% | 0.00% | – |
| Q3 2022 | $87,000 | +29.9% | 35,926 | +5.9% | 0.00% | – |
| Q2 2022 | $67,000 | +644.4% | 33,926 | +543.0% | 0.00% | – |
| Q1 2022 | $9,000 | +50.0% | 5,276 | +23.4% | 0.00% | – |
| Q4 2021 | $6,000 | -57.1% | 4,276 | -65.4% | 0.00% | – |
| Q3 2021 | $14,000 | -39.1% | 12,374 | -10.8% | 0.00% | – |
| Q2 2021 | $23,000 | -45.2% | 13,874 | -42.8% | 0.00% | – |
| Q1 2021 | $42,000 | -51.2% | 24,240 | -45.2% | 0.00% | – |
| Q4 2020 | $86,000 | +4.9% | 44,194 | +28.3% | 0.00% | – |
| Q3 2020 | $82,000 | +446.7% | 34,435 | +588.7% | 0.00% | – |
| Q2 2020 | $15,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |